Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


IJHSR. 2016; 6(10): 68-75

Interleukin 7 in Primary Immune Thrombocytopenia: A Case Control Study.

Nahela Ahmed Shalaby, Shaimaa Abdelmalik Pessar, Radwa Mohamed Salah.

Introduction: Primary immune thrombocytopenia (ITP) is an acquired immune-mediated disorder characterized by isolated thrombocytopenia without any underlying cause. Until recently, the abbreviation ITP stood for idiopathic thrombocytopenic purpura, but current awareness for the immune-mediated nature of the disease, and the absence or minimal signs of bleeding have led to a revision of the terminology. Concepts surrounding the mechanisms of thrombocytopenia in ITP have shifted from the traditional view of increased platelet destruction mediated by auto antibodies to more complex mechanisms in which both impaired platelet production and T cell-mediated effects play a role. Interleukin-7 (IL-7) is a key factor for thymocyte survival and lymph node maturation. Recent studies indicate its important role in autoimmunity; polymorphisms in the IL-7 receptor (IL-7Rα) have been associated with increased risk for autoimmune disease and blocking IL-7Rα antibodies showed therapeutic efficacy in several autoimmune mouse models.
Aim: To evaluate the level of IL-7 in primary immune thrombocytopenia for possibility of being adopted as a reliable marker for ITP.
Materials and Methods: A total of 65 children were enrolled in the study; 45 ITP patients (35 active and 15 in remissions) diagnosed according to recent IWG criteria in The Pediatric Clinic of ASUH and 15 healthy subjects were taken as control group. All were assessed for plasma and BM levels of IL-7 by ELISA.
Results: Our study revealed a significant decrease in plasma IL7 level in both whole ITP patients and active ITP groups than control group, but IL7 level in BM of all patient groups show no significant difference over control. Plasma IL7 has a diagnostic utility in ITP at certain cut-offs.
Conclusion: IL7 can be relied upon as a diagnostic marker for ITP at cut-off (15 pg/ mL). However, its role in prognosis needs further investigations.

Key words: ITP, IL-7, primary immune thrombocytopenia.

Share this Article

American Journal of Research in Medical Sciences


ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons